Trials / Completed
CompletedNCT00296751
Epidural Analgesia Versus IV Meperidine for Labor Pain Control
Epidural Analgesia Versus IV Meperidine for Labor Pain Control. Objective Evaluation of the Pain Intensity Influence on the Autonomic Nervous System.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
60 female that care for pain control during second stage of delivery, will choose between epidural or systemic analgesia. Continuous ECG (3 lead)monitoring will be recorded during the second stage for 10 minutes. 30 minutes after administration of either pain relief, a second recording of maternal ECG will take place for 10 minutes.
Detailed description
Population 60 female during second stage of delivery * Inclusion criteria : all parturients requiring pain relief will choose between systemic or epidural analgesia. * Exclusion Criteria: all parturients with cardiac disease, neurological disease, endocrine disease, diabetes, hypertension or any parturients being treated with medications that might effect the cardiovascular autonomic system. * Method: A 10 minute recording of a 3 lead ECG will be performed during the second stage of the delivery (3-7 CM opening). the parturient will be lying on her left side for that period. * 30 minutes after administration of either epidural or systemic Meperidine for pain relief, a second recording of maternal ECG will take place for 10 minutes. * estimated duration of the procedure about one hour per woman.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ECG recording | |
| PROCEDURE | Epidural catheter insertion | |
| DRUG | Intravenous meperidine injection | |
| DRUG | Epidural Bupivacaine and fentanyl injection |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2006-12-01
- Completion
- 2006-12-01
- First posted
- 2006-02-27
- Last updated
- 2010-07-01
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00296751. Inclusion in this directory is not an endorsement.